<DOC>
	<DOCNO>NCT01464125</DOCNO>
	<brief_summary>The aim study evaluate role azithromycin possible combination partner fosmidomycin protect susceptibility recrudescent infection use monotherapy acute Plasmodium falciparum malaria retain excellent safety profile .</brief_summary>
	<brief_title>Fosmidomycin Azithromycin Acute Uncomplicated Plasmodium Falciparum Malaria ( P. Malaria ) Adults</brief_title>
	<detailed_description>The scientific rationale use combination inhibit ability parasite synthesise isoprenoids , precursor many essential compound include sterol , carotenoid ubiquinone . This effected blockade non-mevalonate pathway fosmidomycin potent inhibitor 1-deoxy-D-xylulose 5-phosphate reductoisomerase couple target protein biosynthesis azithromycin bind 50S ribosomal subunit . This mode action contrast ability human host utilise mevalonate pathway isoprenoid synthesis account safety profile drug mechanism selective toxicity . Moreover affords protection cross resistance exist chemotherapeutic agent . The dose fosmidomycin , equivalent 30mg/kg twice daily three day , select evaluation proof concept study derive high dose administer Phase I safety tolerance study . While recommend dose azithromycin treatment bacterial infection 250mg daily three day , high dose 1500mg daily three day evaluate treatment malaria , combination artesunate quinine .</detailed_description>
	<mesh_term>Malaria</mesh_term>
	<mesh_term>Malaria , Falciparum</mesh_term>
	<mesh_term>Fosfomycin</mesh_term>
	<criteria>male female subject age 15 55 year body mass index ≥ 18.5kg/M2 uncomplicated P falciparum malaria acute manifestation asexual parasitaemia 500uL 100,000uL ability tolerate oral therapy able give inform sign consent sign severe malaria , accord WHO criteria body mass index ≤ 18.5 kg/M2 pregnancy history positive urine test lactation mixed plasmodial infection concomitant disease mask assessment response , include diabetes , uncontrolled hypertension , heart failure , hepatic dysfunction ( alanineamino transferase &gt; 150 U/L ) , renal impairment ( creatinine &gt; 125 umol/L 3 mg/dl ) , haemoglobin &lt; 8g/dl , white cell count &gt; 12000/uL antimalarial treatment within previous 28 day symptomatic AIDS</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>Malaria</keyword>
	<keyword>Plasmodium falciparum</keyword>
	<keyword>acute uncomplicated</keyword>
</DOC>